Physician-supervised biohacker optimization — biological age measurement via epigenetic clocks, NAD+ restoration, senolytic protocols, caloric restriction mimetics, and personalized evidence-based protocol design.
Biohacker Optimization
Physician-supervised biohacker optimization — biological age measurement via epigenetic clocks, NAD+ restoration, senolytic protocols, caloric restriction mimetics, and personalized evidence-based protocol design.
Quick summary
- We help you track how fast your body is aging using proven lab tests.
- Your plan may cover NAD+ support, senolytics, sleep, and food choices.
- A doctor grades every option so you know what has strong proof and what is new.
- We build a clear, step-by-step plan around your own lab results and goals.
This content is for educational purposes only. It does not constitute medical advice or replace clinical consultation. All programs described require physician evaluation and individualized clinical management.
Biohacker Optimization Protocol: Evidence-Based Self-Optimization
Biohacking — the practice of applying systematic, data-driven interventions to improve one's own biology — exists on a wide spectrum. At one end are consumer wellness products marketed with biohacking language that have little or no clinical evidence behind them. At the other end is what Advanced Vitality Group offers in the Biohacker Optimization Protocol: a physician-supervised, biomarker-driven, evidence-grounded program that applies the same clinical standards as conventional medicine to measurable biological self-improvement.
The serious biohacker — someone who has moved beyond generic supplement stacks into the territory of quantified, measurable biology — is our patient. Someone who wants to know their biological age, understand the molecular mechanisms behind why interventions work, and engage with a physician who will communicate evidence levels transparently and design a protocol specific to their biomarker findings.
Key Takeaways
Biological age is measurable through validated methods: epigenetic clocks (GrimAge, DunedinPACE, Horvath clock), phenotypic biomarker panels (GDF-15, NAD+, telomere length, IGF-1, hs-CRP), and functional performance assessments.
NAD+ declines approximately 40–60% between early adulthood and age 60 — Phase 1/2 RCTs demonstrate NMN raises skeletal muscle NAD+ and improves insulin sensitivity (Yoshino M et al., Science, 2021); NR raises blood NAD+ by up to 2.7x (Martens CR et al., Nat Comm, 2018).
The 12 Hallmarks of Aging (Lopez-Otin C et al., Cell, 2023) provide the scientific framework for biohacker optimization targets — each hallmark is measurable and has at least preliminary evidence-based interventions.
Senolytic therapy (dasatinib + quercetin): Phase 2 RCTs demonstrate reduction in senescent cell biomarkers and improvements in physical function — including CNS penetration and neuronal senescence reduction (Gonzales MM et al., Nature Aging, 2023).
GrimAge epigenetic clock predicts lifespan and healthspan more accurately than chronological age — and is modifiable through lifestyle interventions documented in published studies.
All interventions are classified by evidence level at AVG: Grade A (multiple large RCTs), Grade B (Phase 1/2 RCTs), Grade C (preliminary human data), or Investigational (limited human evidence, full informed consent).
What Is Evidence-Based Biohacking?
The biological framework that gives serious biohacking scientific coherence is the Hallmarks of Aging — 12 interconnected biological processes identified by Lopez-Otin and colleagues (Cell, 2023): genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation (inflammaging), and dysbiosis. Each hallmark is measurable. Each has at least preliminary evidence-based intervention strategies.
Biological Age Assessment
Epigenetic Clocks
Epigenetic clocks are computational algorithms that analyze DNA methylation patterns to estimate biological age. The original Horvath clock (2013) estimates biological age across tissue types. GrimAge (Lu AT et al., Nature Aging, 2019) is specifically trained to predict lifespan and healthspan — biological age gaps significantly predict time to death and chronic disease. DunedinPACE measures the current pace of aging, making it sensitive to detecting intervention effects over months rather than years.
Key Phenotypic Aging Biomarkers
| Biomarker | Measures | Target |
|---|---|---|
| NAD+ (whole blood) | Cellular energy, DNA repair, sirtuin activity | Higher correlates with better metabolic health |
| GDF-15 | Mitochondrial stress, cellular aging | Lower is better |
| hs-CRP | Systemic inflammaging | < 1.0 mg/L optimal |
| Telomere length | Cellular replicative history | Longer (age-adjusted) |
| IGF-1 | Anabolic capacity, GH axis | 100–250 ng/mL |
| Omega-3 index | Anti-inflammatory membrane composition | > 8% |
Key Intervention Categories
NAD+ Restoration
NAD+ decline of ~40–60% between early adulthood and age 60 impairs mitochondrial ATP production, DNA repair via PARP-1, sirtuin pathway activation, and circadian rhythm entrainment. Phase 1/2 RCTs have established that oral NMN and NR are safe, bioavailable, and effectively raise cellular NAD+ levels. Yoshino M et al. (Science, 2021) demonstrated 250 mg/day NMN significantly increased skeletal muscle NAD+ and improved insulin sensitivity. NR at 250–1,000 mg/day raised blood NAD+ by up to 2.7x (Martens CR et al., Nature Communications, 2018).
Cellular Senescence and Senolytics
The senolytic combination dasatinib + quercetin (D+Q) has Phase 2 evidence: a Mayo Clinic pilot study showed D+Q reduced senescent cell markers and SASP factors (Kirkland JL et al., EBioMedicine, 2019). A Phase 2 RCT in idiopathic pulmonary fibrosis showed D+Q improved physical performance (Justice JN et al., EBioMedicine, 2019). A Phase 2 Alzheimer's trial demonstrated CNS penetration and reduction of neuronal senescence (Gonzales MM et al., Nature Aging, 2023). Senolytics are presented with full Phase 2 evidence disclosure and explicit acknowledgment of investigational status.
Caloric Restriction Mimetics
Metformin activates AMPK and inhibits mTOR — pathways regulating cellular aging. The TAME trial is currently enrolling 3,000 non-diabetic adults aged 65–79 to evaluate metformin targeting aging as a primary endpoint. Rapamycin — an mTOR inhibitor — extends lifespan in multiple animal species (Harrison DE et al., Nature, 2009). Both are discussed in the context of their current evidence status.
Autophagy Activation
The most evidence-supported autophagy activators are behavioral: intermittent fasting, caloric restriction, and aerobic exercise (induces mitophagy via PGC-1alpha). Urolithin A has demonstrated mitophagy activation in a Phase 1 RCT (Andreux PA et al., Nature Metabolism, 2019) — the first human evidence for pharmacological mitophagy induction.
The Biohacker Optimization Protocol: Structure
| Phase | Timeframe | Components |
|---|---|---|
| 1. Biological Age Assessment | Weeks 1–2 | Full biomarker panel, epigenetic age clock, VO2max, DEXA, neurocognitive battery |
| 2. Protocol Design | Week 3 | Physician review, individualized protocol, evidence briefing, informed consent |
| 3. Protocol Initiation | Weeks 3–12 | Lifestyle optimization, nutritional correction, pharmacological additions, NAD+ precursors |
| 4. Reassessment | Weeks 12–16 | Repeat targeted biomarkers, biological response assessment, protocol optimization |
| 5. Quarterly Monitoring | Ongoing | Quarterly panels, annual comprehensive reassessment, biological age tracking |
Evidence vs. Marketing
The biohacking space is saturated with products and protocols not supported by clinical evidence. Common red flags: studies cited are in cell culture or rodents; samples are small without control groups; the specific product has not been tested — only a related compound; the dose used is below any published positive study; or the company conducting the study has direct financial interest. At Advanced Vitality Group, we apply a consistent standard: human clinical trial evidence (randomized, controlled, adequately powered) at the prescribed dose for the intended application.
Frequently Asked Questions
Scientific References
- Lopez-Otin C, et al. “Hallmarks of aging: An expanding universe.” Cell. 2023;186(2):243–278.
- Yoshino M, et al. “NMN increases muscle insulin sensitivity in prediabetic women.” Science. 2021;372(6547):1224–1229.
- Martens CR, et al. “Chronic NR supplementation is well-tolerated and elevates NAD+.” Nature Communications. 2018;9:1286.
- Justice JN, et al. “Senolytics in idiopathic pulmonary fibrosis.” EBioMedicine. 2019;40:554–563.
- Gonzales MM, et al. “A pilot study of senolytic therapy in Alzheimer's disease.” Nature Aging. 2023;3:161–174.
- Harrison DE, et al. “Rapamycin fed late in life extends lifespan.” Nature. 2009;460(7253):392–395.
- Andreux PA, et al. “The mitophagy activator urolithin A.” Nature Metabolism. 2019;1(6):595–603.
- Barzilai N, et al. “Metformin as a Tool to Target Aging.” Cell Metabolism. 2016;23(6):1060–1065.
- Lee DH, et al. “Leisure-time physical activity and all-cause mortality.” JAMA Internal Medicine. 2022;182(12):1246–1254.
- Lu AT, et al. “DNA methylation GrimAge strongly predicts lifespan.” Nature Aging. 2019.
More in Elite Protocols
View allExecutive Longevity
Advanced cardiovascular risk, hormonal axes, and cognitive testing for senior leaders.
Athlete Performance
Hormonal environment, iron status, VO2max, recovery biology for competitive athletes.
Biohacker Optimization
You are hereBiological age assessment, NAD+ optimization, and senolytic protocols.
Schedule a consultation to assess your biological age and design your personalized optimization program.